These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1253813)

  • 1. The importance of 5-hydroxytryptamine for the induction of harmine tremor and its antagonism by dopaminergic agonists assessed by lesions of the midbrain raphe nuclei.
    Costall B; Kelly DM; Naylor RJ
    Eur J Pharmacol; 1976 Jan; 35(1):109-19. PubMed ID: 1253813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of extrapyramidal function for the induction and antagonism of harmine tremor.
    Kelly DM; Naylor RJ
    Eur J Pharmacol; 1975 May; 32(1):76-86. PubMed ID: 1149829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intracerebral injection study on the role of striatal dopamine and 5-hydroxytryptamine in the production of tremor by harmine.
    Kelly DM; Naylor RJ
    Neuropharmacology; 1976 May; 15(5):303-8. PubMed ID: 934444
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of harmine and brain lesions on apomorphine induced motor activity.
    Westermann KH; Funk K; Pawlowski L
    Pharmacol Biochem Behav; 1976 Jan; 4(1):1-6. PubMed ID: 131324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circling behaviour produced by asymmetric medial raphé nuclei lesions in rats.
    Costall B; Naylor RJ; Marsden CD; Pycock CJ
    J Pharm Pharmacol; 1976 Mar; 28(3):248-9. PubMed ID: 6702
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of brain monoamine systems in the jumping behavior induced in rats by the combination of harmine and apomorphine.
    Takashi K; Kuga T
    Jpn J Pharmacol; 1981 Oct; 31(5):677-88. PubMed ID: 6458722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circling produced by serotonin and dopamine agonists in raphe lesioned rats: a serotonin model.
    Slater P
    Pharmacol Biochem Behav; 1980 Dec; 13(6):817-21. PubMed ID: 7193875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmine-, LON-954- and 5-hydroxytryptophan-induced tremors in rats withdrawn from ethanol.
    Gothóni P
    Acta Pharmacol Toxicol (Copenh); 1985 Jul; 57(1):40-6. PubMed ID: 3876687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of diazepam, L-DOPA and dopamine on the cerebellar and spinal electrical patterns induced by harmine in the rabbit.
    de Trujillo GC; de Carolis AS; Longo VG
    Neuropharmacology; 1977 Jan; 16(1):31-6. PubMed ID: 834361
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of dopaminergic agonists and electrical stimulation of the midbrain raphé on the release of 5-hydroxytryptamine from the cat brain in vivo.
    Chiueh CC; Moore KE
    J Neurochem; 1976 Feb; 26(2):319-24. PubMed ID: 1255195
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of destruction of midbrain raphe nuclei on the behavioral effects of dopaminergic substances and I-tryptophan].
    Allikmets LKh; Zharkovskiĭ AM; Arro AG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1977; 27(5):1030-5. PubMed ID: 563144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tremorigenic agents on the cerebellum: a review of biochemical and electrophysiological data.
    Longo VG; Massotti M
    Int Rev Neurobiol; 1985; 26():315-29. PubMed ID: 2991159
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of aprotinin on the harmine-induced tremor in lymphostatic encephalopathic and normal rats.
    Back G; Seidel G
    Eur J Pharmacol; 1975; 32(02):364-9. PubMed ID: 1080114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lesioning dopamine, noradrenaline and 5-hydroxytryptamine pathways on tremorine-induced tremor and rigidity.
    Dickinson SL; Slater P
    Neuropharmacology; 1982 Aug; 21(8):787-94. PubMed ID: 7121751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification by clonidine of harmine-induced tremors in mice: involvement of serotoninergic system.
    Shukla VK; Garg SK; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):50-7. PubMed ID: 3490237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmine action in rats with lymphostatic encephalopathy.
    Back G; Seidel G
    Pharmacology; 1977; 15(2):127-33. PubMed ID: 847010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice.
    Kawanishi K; Hashimoto Y; Fujiwara M; Kataoka Y; Ueki S
    J Pharmacobiodyn; 1981 Jul; 4(7):520-7. PubMed ID: 6975366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical specificity as the critical determinant of the interrelationship between raphe lesions and morphine analgesia.
    Adler M; Kostowski W; Recchia M; Samanin R
    Eur J Pharmacol; 1975 May; 32(1):39-44. PubMed ID: 1149824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomifensine: a potent dopaminergic agonist of antiparkinson potential.
    Costall B; Kelly DM; Naylor RJ
    Psychopharmacologia; 1975; 41(2):153-64. PubMed ID: 1098084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median midbrain raphe nuclei.
    van de Kar LD; Lorens SA
    Brain Res; 1979 Feb; 162(1):45-54. PubMed ID: 761086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.